The Board of Directors of Clinical Laserthermia Systems AB (publ) resolves on a rights issue of units for an initial amount of approximately 69.3 MSEK
LUND, Sweden, 10 August, 2022 – The board of Directors of Clinical Laserthermia Systems AB (publ), ("CLS" or the "Company") has today, with the support of the authorization from the annual general meeting held on 28 June 2022, resolved on an issue of units, with preferential rights for existing shareholders, for an initial maximum amount of approximately SEK 69.3 million before deduction of transaction related costs, followed by a further maximum amount of approximately SEK 35 million before deduction of transaction related costs referring to the exercise of attached warrants (the "Rights